$TKMR Company News Use caution when investing
Post# of 44845
Posted On: 09/16/2014 11:11:52 AM
$TKMR Company News
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
Tekmira: Much More Than An Ebola Treatment 7:57 p.m. Sept. 14, 2014 - Seeking Alpha
Ebola: Desperate Days Ahead 3:14 p.m. Sept. 11, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
4 Companies To Look At After WHO Ebola Consultation In Geneva 11:51 a.m. Sept. 8, 2014 - Seeking Alpha
Cramer's Lightning Round - We Are Bottom Fishing In Ensco (9/5/14) 4:45 a.m. Sept. 7, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Still Want to Own Freeport-McMoRan 6:00 a.m. Sept. 6, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 7:37 p.m. Sept. 5, 2014 - TheStreet.com
Today's Post-Market Laggard: Tekmira Pharmaceuticals (TKMR) 7:09 p.m. Sept. 5, 2014 - TheStreet.com
J&J Ebola Vaccine Gets Funding, Development to Pick Pace - Analyst Blog 3:37 p.m. Sept. 4, 2014 - Zacks.com
BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog 3:08 p.m. Sept. 2, 2014 - Zacks.com
Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog 2:50 p.m. Sept. 2, 2014 - Zacks.com
Ebola cases accelerating 7:10 a.m. Aug. 28, 2014 - Seeking Alpha
Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest 6:17 p.m. Aug. 27, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade 3:12 p.m. Aug. 27, 2014 - Seeking Alpha
Tekmira Pharmaceuticals: What Does The 'Animal Rule' Mean For Their Ebola Drug Development? 2:28 p.m. Aug. 21, 2014 - Seeking Alpha
Tekmira Up 4% On Positive Ebola-Related Drug Study 11:42 a.m. Aug. 21, 2014 - benzinga.com
Why Tekmira Pharmaceuticals (TLMR) Stock Is Gaining Today 10:30 a.m. Aug. 21, 2014 - TheStreet.com
Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 10:25 a.m. April 1, 2014 - GlobeNewswire
Tekmira Announces Completion of Underwritten Public Offering of Common Stock 1:54 p.m. March 18, 2014 - GlobeNewswire
Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 9:02 a.m. March 13, 2014 - GlobeNewswire
Tekmira Announces Proposed Public Offering of Common Stock 4:40 p.m. March 10, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces Year-End 2013 Results 8:30 a.m. March 6, 2014 - GlobeNewswire
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
Tekmira: Much More Than An Ebola Treatment 7:57 p.m. Sept. 14, 2014 - Seeking Alpha
Ebola: Desperate Days Ahead 3:14 p.m. Sept. 11, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
4 Companies To Look At After WHO Ebola Consultation In Geneva 11:51 a.m. Sept. 8, 2014 - Seeking Alpha
Cramer's Lightning Round - We Are Bottom Fishing In Ensco (9/5/14) 4:45 a.m. Sept. 7, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Still Want to Own Freeport-McMoRan 6:00 a.m. Sept. 6, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 7:37 p.m. Sept. 5, 2014 - TheStreet.com
Today's Post-Market Laggard: Tekmira Pharmaceuticals (TKMR) 7:09 p.m. Sept. 5, 2014 - TheStreet.com
J&J Ebola Vaccine Gets Funding, Development to Pick Pace - Analyst Blog 3:37 p.m. Sept. 4, 2014 - Zacks.com
BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog 3:08 p.m. Sept. 2, 2014 - Zacks.com
Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog 2:50 p.m. Sept. 2, 2014 - Zacks.com
Ebola cases accelerating 7:10 a.m. Aug. 28, 2014 - Seeking Alpha
Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest 6:17 p.m. Aug. 27, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade 3:12 p.m. Aug. 27, 2014 - Seeking Alpha
Tekmira Pharmaceuticals: What Does The 'Animal Rule' Mean For Their Ebola Drug Development? 2:28 p.m. Aug. 21, 2014 - Seeking Alpha
Tekmira Up 4% On Positive Ebola-Related Drug Study 11:42 a.m. Aug. 21, 2014 - benzinga.com
Why Tekmira Pharmaceuticals (TLMR) Stock Is Gaining Today 10:30 a.m. Aug. 21, 2014 - TheStreet.com
Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 10:25 a.m. April 1, 2014 - GlobeNewswire
Tekmira Announces Completion of Underwritten Public Offering of Common Stock 1:54 p.m. March 18, 2014 - GlobeNewswire
Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 9:02 a.m. March 13, 2014 - GlobeNewswire
Tekmira Announces Proposed Public Offering of Common Stock 4:40 p.m. March 10, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces Year-End 2013 Results 8:30 a.m. March 6, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼